PHENOBARBITAL

PHENOBARBITAL was reported 14649 times

PHENOBARBITAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PORPHYRINS STOOL INCREASED 12 0.6667
1 URINE DELTA AMINOLEVULINATE INCREASED 9 0.5000
2 ULTRASOUND OVARY ABNORMAL 11 0.4783
3 URINE COPPER INCREASED 13 0.3250
4 DEVELOPMENTAL GLAUCOMA 20 0.3077
5 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 9 0.2903
6 NEW ONSET REFRACTORY STATUS EPILEPTICUS 29 0.2636
7 ANGIOFIBROMA 17 0.2297
8 INTRA-ABDOMINAL PRESSURE INCREASED 35 0.2229
9 VICTIM OF CHILD ABUSE 48 0.1912
10 CHILD ABUSE 45 0.1737
11 EPIDURAL LIPOMATOSIS 55 0.1599
12 MULTIPLE-DRUG RESISTANCE 468 0.1508
13 HAEMATURIA TRAUMATIC 9 0.1343
14 NECROSIS ISCHAEMIC 56 0.1215
15 LYMPHANGIOLEIOMYOMATOSIS 12 0.1101
16 MYOCARDIAL DEPRESSION 27 0.1047
17 OROPHARYNGEAL OEDEMA 13 0.0897
18 COMA BLISTER 8 0.0889
19 INFANTILE SPASMS 58 0.0802
20 PNEUMATOSIS 35 0.0785
21 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 49 0.0754
22 CONGENITAL APLASIA 23 0.0740
23 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 27 0.0711
24 ANGIOMYOLIPOMA 14 0.0651
25 EPILEPTIC ENCEPHALOPATHY 14 0.0628
26 NEONATAL SEIZURE 13 0.0522
27 MULTIPLE DRUG THERAPY 39 0.0517
28 SEIZURE CLUSTER 41 0.0495
29 ANTICONVULSANT DRUG LEVEL INCREASED 78 0.0483
30 MYOCLONIC EPILEPSY 73 0.0481
31 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 22 0.0470
32 STATUS EPILEPTICUS 523 0.0463
33 ANTICONVULSANT DRUG LEVEL ABNORMAL 8 0.0455
34 LENNOX-GASTAUT SYNDROME 10 0.0441
35 TONIC CONVULSION 62 0.0437
36 BREAST HYPERPLASIA 15 0.0426
37 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 32 0.0425
38 NECROTISING ENTEROCOLITIS NEONATAL 17 0.0419
39 ANTICONVULSANT DRUG LEVEL DECREASED 59 0.0418
40 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 20 0.0412
41 CEREBELLAR ATROPHY 35 0.0397
42 CYTOMEGALOVIRUS HEPATITIS 14 0.0395
43 DRUG WITHDRAWAL CONVULSIONS 70 0.0393
44 VAGAL NERVE STIMULATOR IMPLANTATION 12 0.0392
45 CREATININE RENAL CLEARANCE INCREASED 29 0.0388
46 ATONIC SEIZURES 33 0.0384
47 POSTICTAL PARALYSIS 9 0.0372
48 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 19 0.0355
49 PROPOFOL INFUSION SYNDROME 25 0.0355
50 FOETAL MALFORMATION 38 0.0350
51 CHANGE IN SEIZURE PRESENTATION 22 0.0340
52 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 21 0.0324
53 MENTAL RETARDATION 11 0.0313
54 MACROGLOSSIA 17 0.0309
55 HYPERAMMONAEMIC ENCEPHALOPATHY 53 0.0305
56 SEDATION COMPLICATION 75 0.0294
57 LOW SET EARS 12 0.0292
58 INTELLECTUAL DISABILITY 44 0.0290
59 LARYNGEAL STENOSIS 16 0.0277
60 NECROTISING COLITIS 35 0.0276
61 CLONIC CONVULSION 20 0.0273
62 DROP ATTACKS 16 0.0269
63 PARTIAL SEIZURES 141 0.0269
64 LARYNGOMALACIA 9 0.0269
65 MUSCLE MASS 12 0.0265
66 NOSE DEFORMITY 9 0.0242
67 HYPERAMMONAEMIA 116 0.0232
68 TEMPORAL LOBE EPILEPSY 10 0.0229
69 POOR SUCKING REFLEX 9 0.0227
70 JUVENILE IDIOPATHIC ARTHRITIS 55 0.0225
71 BLINDNESS CORTICAL 11 0.0224
72 GAZE PALSY 38 0.0223
73 FOCAL DYSCOGNITIVE SEIZURES 25 0.0219
74 PERFORATION 17 0.0211
75 EXCESSIVE EYE BLINKING 31 0.0210
76 CHOREOATHETOSIS 14 0.0206
77 MYOCARDIAL FIBROSIS 17 0.0202
78 FOETAL ANTICONVULSANT SYNDROME 24 0.0202
79 TESTICULAR ATROPHY 17 0.0195
80 EHLERS-DANLOS SYNDROME 9 0.0194
81 SYSTOLIC DYSFUNCTION 20 0.0190
82 CLEFT PALATE 36 0.0186
83 FANCONI SYNDROME 26 0.0184
84 MUCOSAL ULCERATION 18 0.0178
85 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 68 0.0178
86 HYPERCHLORAEMIA 11 0.0172
87 PETIT MAL EPILEPSY 87 0.0170
88 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 13 0.0167
89 GINGIVAL HYPERTROPHY 25 0.0165
90 COMPLEX PARTIAL SEIZURES 18 0.0162
91 SUPERINFECTION 24 0.0160
92 CREATININE RENAL CLEARANCE DECREASED 64 0.0160
93 INTESTINAL ISCHAEMIA 87 0.0158
94 THERAPEUTIC PRODUCT CROSS-REACTIVITY 14 0.0157
95 MENTAL DISABILITY 9 0.0156
96 ELECTROENCEPHALOGRAM ABNORMAL 49 0.0155
97 GENERALISED TONIC-CLONIC SEIZURE 254 0.0153
98 CONGENITAL NOSE MALFORMATION 8 0.0150
99 ENCEPHALITIS AUTOIMMUNE 19 0.0144
100 SPINA BIFIDA 30 0.0144
101 APNOEIC ATTACK 8 0.0142
102 SEIZURE 1632 0.0141
103 EPILEPSY 428 0.0140
104 RESPIRATORY DEPRESSION 171 0.0139
105 KOUNIS SYNDROME 31 0.0136
106 WHITE MATTER LESION 17 0.0134
107 ELECTROCARDIOGRAM PR PROLONGATION 10 0.0131
108 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 14 0.0127
109 STEREOTYPY 12 0.0127
110 CEREBRAL PALSY 12 0.0126
111 NYSTAGMUS 67 0.0126
112 CEREBELLAR ATAXIA 12 0.0125
113 CLEFT LIP AND PALATE 14 0.0125
114 DYSMORPHISM 29 0.0123
115 BEHAVIOUR DISORDER 65 0.0120
116 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 309 0.0120
117 TRACHEITIS 9 0.0118
118 ATAXIA 140 0.0118
119 CROSS SENSITIVITY REACTION 11 0.0113
120 ASTERIXIS 12 0.0113
121 PORPHYRIA ACUTE 16 0.0111
122 LEFT VENTRICULAR HYPERTROPHY 46 0.0107
123 CEREBRAL ATROPHY 42 0.0105
124 HYPERTROPHIC CARDIOMYOPATHY 16 0.0103
125 RESPIRATORY ACIDOSIS 40 0.0102
126 HYPERPLASIA 9 0.0100
127 DRUG RESISTANCE 257 0.0100
128 CARDIAC DEATH 12 0.0099
129 PSYCHOMOTOR SKILLS IMPAIRED 26 0.0099
130 QUADRIPARESIS 16 0.0096
131 HYPOTONIA NEONATAL 15 0.0096
132 POSTURE ABNORMAL 31 0.0095
133 RENAL FUNCTION TEST ABNORMAL 44 0.0095
134 CLEFT LIP 8 0.0091
135 AURA 17 0.0091
136 FEBRILE CONVULSION 11 0.0090
137 SEDATION 233 0.0089
138 BRAIN OPERATION 20 0.0088
139 BLOOD LACTIC ACID INCREASED 43 0.0082
140 VENTRICULAR HYPOKINESIA 26 0.0081
141 AMMONIA INCREASED 41 0.0080
142 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 41 0.0080
143 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 21 0.0079
144 DEVELOPMENTAL DELAY 71 0.0079
145 LANGUAGE DISORDER 17 0.0079
146 MICROCEPHALY 10 0.0078
147 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0077
148 HYPOTONIA 76 0.0076
149 APNOEA 59 0.0076
150 PSYCHOMOTOR RETARDATION 21 0.0075
151 HAEMODYNAMIC INSTABILITY 56 0.0073
152 INHIBITORY DRUG INTERACTION 11 0.0069
153 RHINOVIRUS INFECTION 27 0.0069
154 STUPOR 22 0.0068
155 HYPERNATRAEMIA 34 0.0068
156 GROWTH RETARDATION 20 0.0068
157 PNEUMONIA ASPIRATION 168 0.0067
158 BRADYPNOEA 18 0.0067
159 DIABETES INSIPIDUS 16 0.0066
160 SPEECH DISORDER DEVELOPMENTAL 19 0.0066
161 STILLBIRTH 32 0.0066
162 CONVULSION 369 0.0064
163 MUSCLE CONTRACTURE 13 0.0064
164 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 21 0.0063
165 MENINGITIS BACTERIAL 9 0.0063
166 CALCINOSIS 14 0.0063
167 ATROPHY 12 0.0062
168 BLOOD CALCIUM DECREASED 69 0.0061
169 HYPERTONIA 35 0.0061
170 PARAINFLUENZAE VIRUS INFECTION 9 0.0059
171 GASTROSTOMY 9 0.0058
172 STARING 14 0.0058
173 MYOCLONUS 68 0.0057
174 STRABISMUS 16 0.0054
175 RESUSCITATION 9 0.0054
176 DRUG LEVEL DECREASED 55 0.0054
177 HISTIOCYTOSIS HAEMATOPHAGIC 16 0.0054
178 IMPULSIVE BEHAVIOUR 20 0.0053
179 MIXED LIVER INJURY 16 0.0053
180 HUMAN HERPESVIRUS 6 INFECTION 10 0.0053
181 EYE MOVEMENT DISORDER 36 0.0053
182 PRODUCT PRESCRIBING ERROR 124 0.0052
183 HYPOTHERMIA 52 0.0051
184 BILIRUBIN CONJUGATED INCREASED 12 0.0051
185 ATRIOVENTRICULAR BLOCK FIRST DEGREE 22 0.0051
186 COGNITIVE DISORDER 235 0.0050
187 VENTRICULAR DYSFUNCTION 13 0.0050
188 GRAND MAL CONVULSION 46 0.0050
189 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 273 0.0050
190 PERSONALITY DISORDER 13 0.0050
191 ILEUS PARALYTIC 22 0.0049
192 ATRIOVENTRICULAR BLOCK 38 0.0049
193 DRUG LEVEL BELOW THERAPEUTIC 27 0.0049
194 COMA 231 0.0048
195 COMA SCALE ABNORMAL 14 0.0048
196 WRONG PATIENT RECEIVED PRODUCT 14 0.0048
197 CLUMSINESS 13 0.0048
198 EXPOSURE VIA INGESTION 12 0.0048
199 NEUROLOGICAL DECOMPENSATION 11 0.0047
200 METHAEMOGLOBINAEMIA 11 0.0047
201 TOXIC EPIDERMAL NECROLYSIS 72 0.0047
202 HYPOREFLEXIA 9 0.0047
203 SCOLIOSIS 29 0.0047
204 ENDOTRACHEAL INTUBATION 13 0.0046
205 ABDOMINAL WALL HAEMATOMA 9 0.0046
206 HYPERREFLEXIA 16 0.0046
207 IMMOBILE 20 0.0046
208 THROMBOPHLEBITIS 16 0.0046
209 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34 0.0045
210 THROMBOTIC MICROANGIOPATHY 44 0.0045
211 TALIPES 14 0.0045
212 CONJUNCTIVAL HYPERAEMIA 16 0.0045
213 AUTONOMIC NERVOUS SYSTEM IMBALANCE 13 0.0044
214 ACIDOSIS 34 0.0044
215 STRIDOR 13 0.0044
216 GASTROINTESTINAL TUBE INSERTION 11 0.0044
217 MALABSORPTION 23 0.0044
218 SALIVARY HYPERSECRETION 44 0.0044
219 DERMATITIS EXFOLIATIVE 22 0.0044
220 OBESITY 70 0.0044
221 SUBDURAL HAEMORRHAGE 12 0.0044
222 CLONUS 12 0.0044
223 AUTISM SPECTRUM DISORDER 24 0.0044
224 HYPOSPADIAS 9 0.0043
225 HYPERTHERMIA 33 0.0043
226 DEPRESSED LEVEL OF CONSCIOUSNESS 169 0.0043
227 CARDIOTOXICITY 38 0.0043
228 BRAIN DEATH 13 0.0042
229 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 11 0.0042
230 DROOLING 29 0.0042
231 CATATONIA 22 0.0042
232 LEARNING DISORDER 10 0.0041
233 DRUG INTERACTION 656 0.0041
234 AREFLEXIA 11 0.0041
235 HEPATITIS FULMINANT 12 0.0040
236 CARDIAC DYSFUNCTION 15 0.0040
237 PSEUDOMEMBRANOUS COLITIS 9 0.0040
238 TENDERNESS 42 0.0040
239 INTRAVENTRICULAR HAEMORRHAGE 10 0.0040
240 METABOLIC ENCEPHALOPATHY 12 0.0040
241 ATRIOVENTRICULAR BLOCK SECOND DEGREE 12 0.0040
242 TOXIC ENCEPHALOPATHY 20 0.0039
243 STEVENS-JOHNSON SYNDROME 87 0.0039
244 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 28 0.0039
245 GINGIVAL DISORDER 15 0.0039
246 HAEMANGIOMA 9 0.0039
247 BRAIN INJURY 39 0.0039
248 ACTINIC KERATOSIS 10 0.0038
249 TOXICITY TO VARIOUS AGENTS 648 0.0038
250 VENTRICULAR SEPTAL DEFECT 22 0.0038
251 ENTEROCOLITIS 22 0.0038
252 DRUG LEVEL INCREASED 63 0.0038
253 STRESS CARDIOMYOPATHY 22 0.0038
254 PATENT DUCTUS ARTERIOSUS 15 0.0038
255 BRAIN OEDEMA 47 0.0037
256 BUNDLE BRANCH BLOCK RIGHT 17 0.0037
257 ALTERED STATE OF CONSCIOUSNESS 80 0.0037
258 ORTHOSTATIC HYPOTENSION 64 0.0037
259 ACUTE HEPATIC FAILURE 50 0.0037
260 METABOLIC ACIDOSIS 117 0.0037
261 INTESTINAL PERFORATION 41 0.0036
262 VITAMIN D DEFICIENCY 35 0.0036
263 CARDIOMEGALY 44 0.0036
264 ENCEPHALOPATHY 87 0.0035
265 LOW BIRTH WEIGHT BABY 28 0.0035
266 INCREASED BRONCHIAL SECRETION 9 0.0035
267 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 31 0.0035
268 REGURGITATION 12 0.0035
269 SCREAMING 22 0.0035
270 REBOUND EFFECT 39 0.0034
271 HEPATIC ENCEPHALOPATHY 32 0.0034
272 FOETAL EXPOSURE DURING PREGNANCY 273 0.0034
273 HYPOVOLAEMIC SHOCK 16 0.0033
274 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 34 0.0033
275 CACHEXIA 17 0.0033
276 EOSINOPHILIA 57 0.0032
277 CARBOHYDRATE ANTIGEN 125 INCREASED 11 0.0032
278 MULTIPLE ORGAN DYSFUNCTION SYNDROME 91 0.0032
279 THERAPY NON-RESPONDER 144 0.0032
280 ASPIRATION 35 0.0032
281 ENCEPHALITIS 22 0.0032
282 DRUG ABUSE 264 0.0032
283 CIRCULATORY COLLAPSE 54 0.0032
284 COMMUNICATION DISORDER 12 0.0031
285 BRONCHIOLITIS 11 0.0031
286 INGUINAL HERNIA 19 0.0031
287 HYDROCEPHALUS 17 0.0031
288 DRUG LEVEL ABOVE THERAPEUTIC 14 0.0031
289 MALNUTRITION 34 0.0030
290 RESPIRATORY FAILURE 218 0.0030
291 POTENTIATING DRUG INTERACTION 10 0.0030
292 ABORTION INDUCED 28 0.0030
293 EMERGENCY CARE 9 0.0030
294 PRODUCT PREPARATION ISSUE 19 0.0029
295 FAILURE TO THRIVE 15 0.0029
296 HYPOPNOEA 10 0.0029
297 RASH MACULO-PAPULAR 64 0.0029
298 HYPERTRANSAMINASAEMIA 20 0.0029
299 AORTIC VALVE INCOMPETENCE 12 0.0028
300 FIBRIN D DIMER INCREASED 10 0.0028
301 SOCIAL AVOIDANT BEHAVIOUR 16 0.0028
302 COMPLETED SUICIDE 228 0.0027
303 PSYCHOMOTOR HYPERACTIVITY 45 0.0027
304 MATERNAL EXPOSURE DURING BREAST FEEDING 11 0.0027
305 IRRITABILITY 163 0.0027
306 HYPERBILIRUBINAEMIA 28 0.0027
307 NEUROLEPTIC MALIGNANT SYNDROME 32 0.0027
308 FEELING DRUNK 20 0.0027
309 THERAPY PARTIAL RESPONDER 41 0.0026
310 SUBSTANCE ABUSE 21 0.0026
311 COLITIS ISCHAEMIC 17 0.0025
312 TRICUSPID VALVE INCOMPETENCE 20 0.0025
313 RESPIRATORY DISTRESS 69 0.0025
314 CARDIO-RESPIRATORY ARREST 104 0.0025
315 ENURESIS 10 0.0025
316 TREATMENT FAILURE 202 0.0024
317 PRODUCT ADMINISTRATION INTERRUPTED 19 0.0024
318 AGGRESSION 121 0.0024
319 LEFT VENTRICULAR DYSFUNCTION 16 0.0024
320 SNORING 9 0.0024
321 LEUKOCYTOSIS 43 0.0024
322 ABNORMAL BEHAVIOUR 94 0.0024
323 MYOCARDIAL ISCHAEMIA 27 0.0024
324 CYANOSIS 37 0.0024
325 DIPLOPIA 61 0.0023
326 COAGULOPATHY 39 0.0023
327 SOMNOLENCE 469 0.0023
328 RHABDOMYOLYSIS 97 0.0023
329 HYPONATRAEMIA 131 0.0023
330 CARDIAC ARREST 192 0.0023
331 RESPIRATORY ARREST 64 0.0023
332 MULTI-ORGAN FAILURE 40 0.0023
333 MATERNAL EXPOSURE DURING PREGNANCY 205 0.0023
334 CEREBRAL DISORDER 17 0.0023
335 BRADYPHRENIA 15 0.0023
336 ATRIAL SEPTAL DEFECT 19 0.0023
337 SHOCK 52 0.0023
338 HAND FRACTURE 16 0.0023
339 WHEELCHAIR USER 10 0.0022
340 ELECTROLYTE IMBALANCE 26 0.0022
341 GRAFT VERSUS HOST DISEASE 16 0.0022
342 COORDINATION ABNORMAL 31 0.0022
343 HYPOCALCAEMIA 42 0.0022
344 MATERNAL DRUGS AFFECTING FOETUS 17 0.0022
345 HEMIPARESIS 37 0.0022
346 DYSARTHRIA 82 0.0022
347 SOCIAL PROBLEM 9 0.0022
348 SINUS BRADYCARDIA 21 0.0022
349 HEPATITIS 55 0.0021
350 DYSKINESIA 87 0.0021
351 RESPIRATORY RATE INCREASED 19 0.0021
352 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
353 PREMATURE DELIVERY 34 0.0021
354 TIBIA FRACTURE 10 0.0021
355 UNRESPONSIVE TO STIMULI 55 0.0021
356 ABORTION SPONTANEOUS 84 0.0021
357 MENINGITIS 14 0.0021
358 DRUG WITHDRAWAL SYNDROME NEONATAL 31 0.0021
359 CLAVICLE FRACTURE 8 0.0021
360 APHASIA 63 0.0021
361 POISONING 26 0.0021
362 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
363 PRESCRIBED OVERDOSE 40 0.0021
364 AGITATION 151 0.0021
365 BRADYCARDIA 109 0.0021
366 HYPERTRIGLYCERIDAEMIA 12 0.0020
367 GINGIVAL SWELLING 9 0.0020
368 HYPOTENSION 408 0.0020
369 LETHARGY 116 0.0020
370 ILEUS 25 0.0020
371 OXYGEN SATURATION DECREASED 112 0.0020
372 TACHYPNOEA 27 0.0020
373 VASCULAR DEVICE INFECTION 9 0.0020
374 MENTAL STATUS CHANGES 55 0.0020
375 SUICIDE ATTEMPT 120 0.0020
376 CHOLESTASIS 38 0.0020
377 BALANCE DISORDER 171 0.0020
378 CARDIAC MURMUR 17 0.0020
379 MOTOR DYSFUNCTION 20 0.0020
380 CARDIAC FAILURE ACUTE 13 0.0019
381 GENERALISED ERYTHEMA 11 0.0019
382 ERYTHEMA MULTIFORME 18 0.0019
383 VENTRICULAR EXTRASYSTOLES 20 0.0019
384 WRONG PRODUCT ADMINISTERED 13 0.0019
385 SUSPECTED SUICIDE 9 0.0019
386 EXPOSURE DURING PREGNANCY 119 0.0019
387 TACHYCARDIA 169 0.0019
388 OSTEOPOROSIS 78 0.0019
389 DRUG INEFFECTIVE 2499 0.0019
390 SERUM FERRITIN INCREASED 10 0.0019
391 HYPOPHOSPHATAEMIA 14 0.0019
392 PREMATURE BABY 57 0.0019
393 BUNDLE BRANCH BLOCK LEFT 8 0.0019
394 LACTIC ACIDOSIS 61 0.0019
395 VITAMIN D DECREASED 16 0.0019
396 INTENTIONAL OVERDOSE 118 0.0018
397 URINE OUTPUT DECREASED 16 0.0018
398 ABSCESS 29 0.0018
399 VENTRICULAR TACHYCARDIA 30 0.0018
400 ACUTE RESPIRATORY DISTRESS SYNDROME 32 0.0018
401 FOETAL GROWTH RESTRICTION 11 0.0018
402 DRUG ERUPTION 32 0.0018
403 HEPATIC CYTOLYSIS 23 0.0018
404 BLOOD SODIUM DECREASED 34 0.0018
405 PELVIC FRACTURE 14 0.0018
406 OSTEOPENIA 27 0.0018
407 DRUG TOLERANCE 9 0.0018
408 MAJOR DEPRESSION 13 0.0018
409 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
410 FEEDING DISORDER 36 0.0018
411 MOUTH HAEMORRHAGE 13 0.0018
412 PREMATURE LABOUR 10 0.0018
413 PRODUCT USE ISSUE 330 0.0018
414 PULMONARY CONGESTION 23 0.0017
415 HYPERSOMNIA 50 0.0017
416 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
417 HEAD INJURY 55 0.0017
418 HEPATIC FAILURE 52 0.0017
419 NO THERAPEUTIC RESPONSE 21 0.0017
420 SPLENOMEGALY 20 0.0017
421 LEARNING DISABILITY 9 0.0017
422 DRUG-INDUCED LIVER INJURY 53 0.0017
423 FOOT FRACTURE 32 0.0017
424 MITRAL VALVE INCOMPETENCE 19 0.0017
425 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
426 DELIRIUM 58 0.0017
427 OFF LABEL USE 1463 0.0017
428 DYSGRAPHIA 11 0.0017
429 PULMONARY HAEMORRHAGE 13 0.0017
430 NONSPECIFIC REACTION 9 0.0016
431 PNEUMONIA BACTERIAL 15 0.0016
432 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
433 SPEECH DISORDER 85 0.0016
434 LIGAMENT SPRAIN 16 0.0016
435 ACUTE RESPIRATORY FAILURE 31 0.0016
436 JOINT DISLOCATION 17 0.0016
437 MUSCLE TWITCHING 37 0.0016
438 CARDIOGENIC SHOCK 23 0.0016
439 CRYING 58 0.0016
440 SPINAL OSTEOARTHRITIS 14 0.0016
441 CHOLECYSTITIS ACUTE 9 0.0016
442 MANIA 26 0.0016
443 OVERDOSE 337 0.0016
444 LOWER LIMB FRACTURE 30 0.0016
445 PRODUCT USE IN UNAPPROVED INDICATION 386 0.0016
446 HEPATIC FUNCTION ABNORMAL 58 0.0016
447 INCOHERENT 10 0.0015
448 DRUG TOXICITY 21 0.0015
449 RESPIRATORY DISORDER 46 0.0015
450 PANCREATITIS 81 0.0015
451 HEPATOMEGALY 15 0.0015
452 INTENTIONAL PRODUCT MISUSE 133 0.0015
453 URINARY INCONTINENCE 45 0.0015
454 WALKING AID USER 10 0.0015
455 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
456 BLADDER DISORDER 15 0.0015
457 ODYNOPHAGIA 9 0.0015
458 AGRANULOCYTOSIS 28 0.0015
459 ELECTROCARDIOGRAM QT PROLONGED 54 0.0015
460 COMPRESSION FRACTURE 8 0.0015
461 PSYCHIATRIC SYMPTOM 11 0.0015
462 HYPOXIA 52 0.0015
463 RESTLESSNESS 54 0.0015
464 CONDITION AGGRAVATED 446 0.0015
465 EAR INFECTION 39 0.0015
466 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 9 0.0015
467 ISCHAEMIC STROKE 26 0.0015
468 UPPER LIMB FRACTURE 29 0.0015
469 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 102 0.0014
470 BLOOD UREA INCREASED 24 0.0014
471 WITHDRAWAL SYNDROME 60 0.0014
472 POOR QUALITY PRODUCT ADMINISTERED 15 0.0014
473 THROMBOCYTOPENIA 159 0.0014
474 WRIST FRACTURE 17 0.0014
475 SLEEP APNOEA SYNDROME 27 0.0014
476 VIRAL INFECTION 47 0.0014
477 ENTERITIS 9 0.0014
478 MYDRIASIS 18 0.0014
479 AFFECTIVE DISORDER 11 0.0014
480 AMNESIA 91 0.0014
481 POOR QUALITY DRUG ADMINISTERED 9 0.0014
482 PHARYNGITIS 17 0.0014
483 ANGER 46 0.0014
484 PRESCRIBED UNDERDOSE 27 0.0014
485 DECUBITUS ULCER 11 0.0013
486 ATELECTASIS 13 0.0013
487 RESPIRATORY TRACT INFECTION 35 0.0013
488 PETECHIAE 14 0.0013
489 HYPERLIPIDAEMIA 16 0.0013
490 NERVOUS SYSTEM DISORDER 41 0.0013
491 RIB FRACTURE 27 0.0013
492 SEPTIC SHOCK 57 0.0013
493 HEPATOTOXICITY 29 0.0013
494 LARGE INTESTINE PERFORATION 9 0.0013
495 CONGENITAL ANOMALY 10 0.0013
496 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
497 DEMENTIA 36 0.0013
498 MENTAL IMPAIRMENT 31 0.0013
499 LYMPHADENOPATHY 45 0.0013
500 NEUTROPHIL COUNT INCREASED 13 0.0013
501 MOBILITY DECREASED 91 0.0013
502 TRANSAMINASES INCREASED 28 0.0013
503 POLYNEUROPATHY 15 0.0013
504 BLOOD DISORDER 10 0.0012
505 PANCREATITIS ACUTE 28 0.0012
506 LYMPHOCYTE COUNT DECREASED 22 0.0012
507 FALL 410 0.0012
508 FEMUR FRACTURE 38 0.0012
509 ANAL INCONTINENCE 11 0.0012
510 MUSCLE SPASTICITY 15 0.0012
511 HICCUPS 10 0.0012
512 HYPERCALCAEMIA 15 0.0012
513 ABDOMINAL DISTENSION 126 0.0012
514 INCREASED APPETITE 23 0.0012
515 CYTOMEGALOVIRUS INFECTION 20 0.0012
516 TOXIC SKIN ERUPTION 12 0.0012
517 HAEMODIALYSIS 10 0.0012
518 INTENTIONAL SELF-INJURY 24 0.0012
519 DISORIENTATION 47 0.0012
520 TREATMENT NONCOMPLIANCE 64 0.0012
521 APATHY 17 0.0012
522 IMPAIRED DRIVING ABILITY 13 0.0011
523 SEPSIS 127 0.0011
524 INCONTINENCE 12 0.0011
525 LIVER FUNCTION TEST ABNORMAL 33 0.0011
526 BLOOD ALBUMIN DECREASED 9 0.0011
527 NEOPLASM 13 0.0011
528 PARKINSONISM 11 0.0011
529 CHOKING 22 0.0011
530 HYPOTHYROIDISM 36 0.0011
531 PYREXIA 389 0.0011
532 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
533 SUBDURAL HAEMATOMA 16 0.0011
534 BODY TEMPERATURE DECREASED 11 0.0011
535 BLOOD POTASSIUM INCREASED 18 0.0011
536 DRUG DEPENDENCE 178 0.0011
537 DERMATITIS BULLOUS 8 0.0011
538 SLEEP DISORDER 78 0.0011
539 BACK INJURY 12 0.0011
540 THYROID DISORDER 17 0.0011
541 ASPHYXIA 9 0.0011
542 HALLUCINATION, VISUAL 23 0.0011
543 DENTAL CARIES 12 0.0011
544 IRON DEFICIENCY ANAEMIA 10 0.0011
545 DYSTONIA 21 0.0011
546 FOOT DEFORMITY 12 0.0011
547 URINARY RETENTION 36 0.0011
548 PNEUMOTHORAX 17 0.0011
549 LIVER FUNCTION TEST INCREASED 23 0.0011
550 SCHIZOPHRENIA 13 0.0011
551 LACERATION 10 0.0011
552 CHROMATURIA 24 0.0011
553 SQUAMOUS CELL CARCINOMA 10 0.0011
554 HAEMATOCRIT DECREASED 21 0.0011
555 DRUG EXPOSURE DURING PREGNANCY 36 0.0011
556 SPINAL DISORDER 10 0.0011
557 TREMOR 175 0.0011
558 SCAB 12 0.0011
559 DISEASE RECURRENCE 50 0.0011
560 GENERALISED OEDEMA 13 0.0010
561 PRODUCT CONTAINER ISSUE 9 0.0010
562 PSEUDOMONAS INFECTION 9 0.0010
563 PREGNANCY 21 0.0010
564 ANURIA 9 0.0010
565 ALANINE AMINOTRANSFERASE INCREASED 64 0.0010
566 LOSS OF CONSCIOUSNESS 133 0.0010
567 PNEUMONIA 335 0.0010
568 DERMATITIS ALLERGIC 13 0.0010
569 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 8 0.0010
570 PALLOR 28 0.0010
571 BODY HEIGHT DECREASED 11 0.0010
572 DYSSTASIA 30 0.0010
573 MUSCLE ATROPHY 13 0.0010
574 LIVER INJURY 25 0.0010
575 HYPOKALAEMIA 47 0.0010
576 CARDIOMYOPATHY 15 0.0010
577 SKIN LACERATION 11 0.0010
578 BACTERAEMIA 12 0.0010
579 DRUG DOSE OMISSION 167 0.0010
580 PRODUCT AVAILABILITY ISSUE 23 0.0010
581 PULMONARY OEDEMA 45 0.0010
582 TOOTH FRACTURE 11 0.0010
583 ASPARTATE AMINOTRANSFERASE INCREASED 53 0.0010
584 MOVEMENT DISORDER 32 0.0010
585 LIVER DISORDER 44 0.0010
586 CONFUSIONAL STATE 160 0.0010
587 NERVE INJURY 11 0.0010
588 BEDRIDDEN 13 0.0010
589 EATING DISORDER 21 0.0010
590 CONSTIPATION 214 0.0010
591 SOPOR 13 0.0010
592 NEPHROLITHIASIS 45 0.0010
593 HYPOPHAGIA 25 0.0010
594 STAPHYLOCOCCAL INFECTION 32 0.0010
595 PERSONALITY CHANGE 9 0.0010
596 HYPOKINESIA 14 0.0010
597 HAEMATURIA 33 0.0010
598 GAIT DISTURBANCE 184 0.0010
599 SECRETION DISCHARGE 12 0.0010
600 FRACTURE 18 0.0009
601 FACE OEDEMA 16 0.0009
602 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
603 EYELID OEDEMA 11 0.0009
604 SUDDEN DEATH 10 0.0009
605 PRODUCT ADMINISTRATION ERROR 19 0.0009
606 IMMUNODEFICIENCY 14 0.0009
607 SPINAL PAIN 11 0.0009
608 BONE DISORDER 17 0.0009
609 END STAGE RENAL DISEASE 17 0.0009
610 GAIT INABILITY 31 0.0009
611 DEEP VEIN THROMBOSIS 60 0.0009
612 ACCIDENT 11 0.0009
613 PLATELET COUNT INCREASED 12 0.0009
614 NEUROTOXICITY 16 0.0009
615 PULMONARY HYPERTENSION 19 0.0009
616 DISABILITY 18 0.0009
617 IMPAIRED QUALITY OF LIFE 13 0.0009
618 HIP FRACTURE 29 0.0009
619 FUNGAL INFECTION 30 0.0009
620 ACUTE KIDNEY INJURY 137 0.0009
621 SMALL INTESTINAL OBSTRUCTION 11 0.0009
622 HEART RATE INCREASED 88 0.0009
623 EXTRAPYRAMIDAL DISORDER 22 0.0009
624 PSYCHOTIC DISORDER 26 0.0009
625 HEPATIC ENZYME INCREASED 60 0.0009
626 MOOD ALTERED 24 0.0009
627 EUPHORIC MOOD 9 0.0009
628 EMOTIONAL DISORDER 27 0.0009
629 INTERNAL HAEMORRHAGE 10 0.0009
630 GASTRIC HAEMORRHAGE 10 0.0009
631 MUSCLE TIGHTNESS 14 0.0009
632 CAESAREAN SECTION 10 0.0009
633 FEAR 23 0.0009
634 BRONCHITIS 63 0.0009
635 ANAPHYLACTIC REACTION 47 0.0008
636 MENTAL DISORDER 37 0.0008
637 RASH GENERALISED 22 0.0008
638 ACCIDENTAL OVERDOSE 31 0.0008
639 MOOD SWINGS 27 0.0008
640 ARRHYTHMIA 40 0.0008
641 ANKLE FRACTURE 13 0.0008
642 PARALYSIS 12 0.0008
643 DISEASE PROGRESSION 99 0.0008
644 ROAD TRAFFIC ACCIDENT 35 0.0008
645 GASTRITIS 22 0.0008
646 IMMUNE SYSTEM DISORDER 11 0.0008
647 THROMBOSIS 67 0.0008
648 PRURITUS GENERALISED 18 0.0008
649 AFFECT LABILITY 8 0.0008
650 HAEMATEMESIS 21 0.0008
651 URINARY TRACT INFECTION 141 0.0008
652 PRODUCT PRESCRIBING ISSUE 18 0.0008
653 MEMORY IMPAIRMENT 113 0.0008
654 PERITONITIS 17 0.0008
655 TOOTH LOSS 17 0.0008
656 DECREASED APPETITE 189 0.0008
657 HOSPITALISATION 125 0.0008
658 SENSORY DISTURBANCE 13 0.0008
659 BLINDNESS 33 0.0008
660 RENAL FAILURE 107 0.0008
661 DYSPHAGIA 76 0.0008
662 DISTURBANCE IN ATTENTION 43 0.0008
663 HALLUCINATION 60 0.0008
664 DERMATITIS CONTACT 9 0.0008
665 APHONIA 11 0.0008
666 DRUG DISPENSING ERROR 12 0.0008
667 PRODUCT SUBSTITUTION ISSUE 45 0.0008
668 JAUNDICE 21 0.0008
669 EJECTION FRACTION DECREASED 12 0.0008
670 SEXUAL DYSFUNCTION 9 0.0008
671 BRAIN FOG 12 0.0008
672 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
673 DIABETES MELLITUS 58 0.0008
674 WEIGHT DECREASED 212 0.0008
675 FLATULENCE 43 0.0008
676 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
677 FLUID OVERLOAD 11 0.0008
678 HALLUCINATION, AUDITORY 12 0.0008
679 CHRONIC KIDNEY DISEASE 57 0.0007
680 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
681 LOCAL SWELLING 13 0.0007
682 DRUG EFFECT INCOMPLETE 27 0.0007
683 MUSCULAR WEAKNESS 84 0.0007
684 MEDICATION ERROR 41 0.0007
685 UPPER RESPIRATORY TRACT INFECTION 34 0.0007
686 PERICARDIAL EFFUSION 17 0.0007
687 AKATHISIA 10 0.0007
688 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
689 INSOMNIA 193 0.0007
690 CYSTITIS 23 0.0007
691 OEDEMA 39 0.0007
692 DEPRESSED MOOD 38 0.0007
693 SKIN DISCOLOURATION 33 0.0007
694 INTENTIONAL DRUG MISUSE 15 0.0007
695 CONTUSION 69 0.0007
696 VOMITING 336 0.0007
697 INFECTION 103 0.0007
698 MUSCULOSKELETAL CHEST PAIN 11 0.0007
699 RENAL INJURY 21 0.0007
700 RENAL IMPAIRMENT 59 0.0007
701 CONJUNCTIVITIS 13 0.0007
702 EYE DISORDER 23 0.0007
703 LIMB INJURY 19 0.0007
704 SPINAL FRACTURE 14 0.0007
705 PRODUCT USE COMPLAINT 11 0.0007
706 BACTERIAL INFECTION 13 0.0007
707 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
708 ABASIA 17 0.0007
709 C-REACTIVE PROTEIN INCREASED 25 0.0007
710 BLOOD CHOLESTEROL INCREASED 32 0.0007
711 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
712 ANAEMIA 130 0.0007
713 WOUND 19 0.0007
714 LEUKOPENIA 34 0.0007
715 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
716 COVID-19 PNEUMONIA 8 0.0007
717 THERAPEUTIC RESPONSE DECREASED 41 0.0007
718 RECTAL HAEMORRHAGE 29 0.0007
719 DRUG INTOLERANCE 65 0.0007
720 CATARACT 40 0.0007
721 CEREBRAL HAEMORRHAGE 24 0.0007
722 NEUTROPENIA 91 0.0007
723 PHOTOSENSITIVITY REACTION 11 0.0007
724 INTESTINAL OBSTRUCTION 25 0.0007
725 BLOOD PRESSURE DECREASED 44 0.0007
726 RESTLESS LEGS SYNDROME 12 0.0007
727 CORONARY ARTERY OCCLUSION 9 0.0007
728 SKIN LESION 18 0.0007
729 JOINT INJURY 14 0.0007
730 IMPAIRED WORK ABILITY 14 0.0007
731 CYTOPENIA 8 0.0007
732 DYSURIA 24 0.0007
733 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
734 NERVOUSNESS 34 0.0007
735 POOR QUALITY SLEEP 14 0.0006
736 DEVICE RELATED INFECTION 10 0.0006
737 SYNCOPE 65 0.0006
738 ORAL DISCOMFORT 9 0.0006
739 HYPOMAGNESAEMIA 9 0.0006
740 DEPRESSION 147 0.0006
741 DEHYDRATION 86 0.0006
742 THINKING ABNORMAL 12 0.0006
743 MIDDLE INSOMNIA 12 0.0006
744 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
745 BLINDNESS UNILATERAL 9 0.0006
746 BODY TEMPERATURE INCREASED 13 0.0006
747 SUICIDAL IDEATION 58 0.0006
748 HYPERGLYCAEMIA 23 0.0006
749 ULCER 10 0.0006
750 DRUG PRESCRIBING ERROR 12 0.0006
751 GLAUCOMA 12 0.0006
752 HAEMATOMA 16 0.0006
753 GASTROENTERITIS 9 0.0006
754 INTENTIONAL PRODUCT USE ISSUE 54 0.0006
755 WEIGHT INCREASED 138 0.0006
756 CEREBRAL INFARCTION 15 0.0006
757 ADVERSE DRUG REACTION 55 0.0006
758 VISION BLURRED 84 0.0006
759 RETCHING 13 0.0006
760 HYPERSENSITIVITY 113 0.0006
761 PLEURAL EFFUSION 37 0.0006
762 BLISTER 34 0.0006
763 PULMONARY MASS 9 0.0006
764 ADVERSE REACTION 8 0.0006
765 ASTHENIA 226 0.0006
766 HAEMATOCHEZIA 33 0.0006
767 CARDIAC FAILURE 48 0.0006
768 CORONARY ARTERY DISEASE 18 0.0006
769 BLOOD BILIRUBIN INCREASED 16 0.0006
770 HYPERTENSION 125 0.0006
771 RENAL FAILURE ACUTE 25 0.0006
772 RASH ERYTHEMATOUS 28 0.0006
773 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
774 PRODUCT DOSE OMISSION 38 0.0006
775 DIZZINESS 289 0.0006
776 PROTEINURIA 11 0.0006
777 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
778 LABORATORY TEST ABNORMAL 17 0.0006
779 DEAFNESS 15 0.0006
780 VISUAL IMPAIRMENT 71 0.0006
781 SEROTONIN SYNDROME 11 0.0006
782 CARPAL TUNNEL SYNDROME 8 0.0006
783 LIP SWELLING 19 0.0006
784 HEART RATE DECREASED 20 0.0006
785 GASTROINTESTINAL DISORDER 51 0.0006
786 DEVICE OCCLUSION 8 0.0006
787 NEUROPATHY PERIPHERAL 54 0.0006
788 DRY MOUTH 46 0.0006
789 HEAD DISCOMFORT 10 0.0006
790 FEELING ABNORMAL 135 0.0006
791 MUSCULOSKELETAL STIFFNESS 49 0.0006
792 RENAL DISORDER 26 0.0006
793 VERTIGO 34 0.0006
794 HYPOGLYCAEMIA 27 0.0006
795 WHEEZING 33 0.0006
796 RASH 242 0.0006
797 GASTROENTERITIS VIRAL 10 0.0006
798 TOOTHACHE 10 0.0006
799 PANIC ATTACK 20 0.0005
800 HAEMOGLOBIN DECREASED 56 0.0005
801 INFLAMMATION 28 0.0005
802 OSTEOARTHRITIS 23 0.0005
803 OEDEMA PERIPHERAL 66 0.0005
804 CHEST PAIN 100 0.0005
805 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
806 COUGH 150 0.0005
807 TYPE 2 DIABETES MELLITUS 18 0.0005
808 UNDERDOSE 39 0.0005
809 MUSCLE SPASMS 98 0.0005
810 LUNG DISORDER 26 0.0005
811 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
812 COLITIS 20 0.0005
813 SCAR 9 0.0005
814 CEREBROVASCULAR ACCIDENT 89 0.0005
815 PRODUCTIVE COUGH 25 0.0005
816 HERNIA 10 0.0005
817 ANXIETY 147 0.0005
818 DYSPNOEA 292 0.0005
819 UNEVALUABLE EVENT 39 0.0005
820 MIGRAINE 49 0.0005
821 NO ADVERSE EVENT 93 0.0005
822 HYPERKALAEMIA 18 0.0005
823 IRRITABLE BOWEL SYNDROME 11 0.0005
824 HYPOACUSIS 22 0.0005
825 ACUTE MYOCARDIAL INFARCTION 15 0.0005
826 EPISTAXIS 38 0.0005
827 FAECES DISCOLOURED 11 0.0005
828 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
829 DRUG WITHDRAWAL SYNDROME 44 0.0005
830 DIABETIC KETOACIDOSIS 12 0.0005
831 FULL BLOOD COUNT DECREASED 10 0.0005
832 ANHEDONIA 13 0.0005
833 TOOTH DISORDER 11 0.0005
834 SURGERY 29 0.0005
835 NEURALGIA 12 0.0005
836 FLUSHING 50 0.0005
837 BLOOD CREATININE INCREASED 32 0.0005
838 DRUG ADMINISTRATION ERROR 15 0.0005
839 INFLUENZA 54 0.0005
840 HEPATIC STEATOSIS 9 0.0005
841 NECK PAIN 27 0.0005
842 SWOLLEN TONGUE 15 0.0005
843 DYSPHONIA 28 0.0005
844 DIARRHOEA 309 0.0005
845 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
846 PNEUMONITIS 13 0.0005
847 HEADACHE 299 0.0005
848 NASAL CONGESTION 28 0.0005
849 HYPERHIDROSIS 61 0.0005
850 FEELING JITTERY 9 0.0005
851 FLUID RETENTION 24 0.0005
852 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
853 POST PROCEDURAL COMPLICATION 9 0.0005
854 THERAPY CESSATION 24 0.0005
855 ERECTILE DYSFUNCTION 12 0.0005
856 ANAPHYLACTIC SHOCK 12 0.0005
857 OROPHARYNGEAL PAIN 43 0.0005
858 ABDOMINAL PAIN UPPER 95 0.0005
859 FATIGUE 358 0.0005
860 ABDOMINAL PAIN 106 0.0005
861 INJURY 32 0.0005
862 RED BLOOD CELL COUNT DECREASED 13 0.0005
863 COLD SWEAT 8 0.0005
864 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 32 0.0004
865 INCORRECT ROUTE OF DRUG ADMINISTRATION 16 0.0004
866 PAIN 274 0.0004
867 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
868 PALPITATIONS 52 0.0004
869 MALAISE 194 0.0004
870 GENERAL PHYSICAL HEALTH DETERIORATION 51 0.0004
871 MUSCULOSKELETAL PAIN 23 0.0004
872 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 79 0.0004
873 CARDIAC DISORDER 41 0.0004
874 SWELLING 41 0.0004
875 ATRIAL FIBRILLATION 42 0.0004
876 HYPOAESTHESIA 64 0.0004
877 MOUTH ULCERATION 9 0.0004
878 ILLNESS 44 0.0004
879 CHOLELITHIASIS 14 0.0004
880 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
881 PERIPHERAL SWELLING 65 0.0004
882 VISUAL ACUITY REDUCED 14 0.0004
883 HAEMORRHAGE 44 0.0004
884 SKIN DISORDER 14 0.0004
885 BLOOD PRESSURE INCREASED 64 0.0004
886 BACK PAIN 97 0.0004
887 DYSPEPSIA 41 0.0004
888 BLOOD PRESSURE FLUCTUATION 10 0.0004
889 SKIN EXFOLIATION 35 0.0004
890 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
891 SINUSITIS 42 0.0004
892 DISCOMFORT 25 0.0004
893 ARTHRITIS 32 0.0004
894 URTICARIA 68 0.0004
895 PAIN IN EXTREMITY 118 0.0004
896 RASH MACULAR 14 0.0004
897 DEATH 344 0.0004
898 PRODUCT DOSE OMISSION ISSUE 117 0.0004
899 NASOPHARYNGITIS 73 0.0004
900 ARTHROPATHY 22 0.0004
901 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
902 HAEMOPTYSIS 11 0.0004
903 CARDIOVASCULAR DISORDER 10 0.0004
904 INTERSTITIAL LUNG DISEASE 19 0.0004
905 TINNITUS 18 0.0004
906 EXPIRED PRODUCT ADMINISTERED 13 0.0004
907 LIMB DISCOMFORT 12 0.0004
908 PLATELET COUNT DECREASED 41 0.0004
909 ANGINA PECTORIS 11 0.0004
910 HERPES ZOSTER 22 0.0004
911 PULMONARY EMBOLISM 36 0.0004
912 THERAPY INTERRUPTED 27 0.0004
913 NAUSEA 299 0.0004
914 PANCYTOPENIA 21 0.0004
915 NIGHT SWEATS 12 0.0004
916 DRUG EFFECT DECREASED 20 0.0004
917 FIBROMYALGIA 9 0.0004
918 FREQUENT BOWEL MOVEMENTS 10 0.0004
919 MYOCARDIAL INFARCTION 64 0.0004
920 COVID-19 64 0.0004
921 LACRIMATION INCREASED 11 0.0004
922 ILL-DEFINED DISORDER 22 0.0004
923 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 73 0.0004
924 POLLAKIURIA 15 0.0004
925 ADVERSE EVENT 33 0.0004
926 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
927 RHINORRHOEA 23 0.0004
928 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
929 PRODUCT QUALITY ISSUE 48 0.0004
930 BONE DENSITY DECREASED 11 0.0004
931 INTENTIONAL DOSE OMISSION 10 0.0004
932 GASTRIC DISORDER 12 0.0003
933 CARDIAC FAILURE CONGESTIVE 28 0.0003
934 SKIN ULCER 9 0.0003
935 JOINT SWELLING 42 0.0003
936 JOINT STIFFNESS 9 0.0003
937 INFLUENZA LIKE ILLNESS 28 0.0003
938 ASCITES 10 0.0003
939 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
940 BLOOD GLUCOSE DECREASED 16 0.0003
941 BLOOD POTASSIUM DECREASED 10 0.0003
942 RASH PRURITIC 18 0.0003
943 ECZEMA 17 0.0003
944 FEELING COLD 9 0.0003
945 EYE SWELLING 12 0.0003
946 SWELLING FACE 21 0.0003
947 DRY EYE 16 0.0003
948 PRURITUS 123 0.0003
949 ARTHRALGIA 133 0.0003
950 DYSPNOEA EXERTIONAL 12 0.0003
951 OCULAR HYPERAEMIA 15 0.0003
952 INCORRECT DOSE ADMINISTERED 72 0.0003
953 PARAESTHESIA 49 0.0003
954 BONE PAIN 18 0.0003
955 ERYTHEMA 62 0.0003
956 EYE PAIN 17 0.0003
957 ASTHMA 34 0.0003
958 DRY SKIN 40 0.0003
959 CELLULITIS 15 0.0003
960 NEUTROPHIL COUNT DECREASED 12 0.0003
961 MYALGIA 50 0.0003
962 CHEST DISCOMFORT 30 0.0003
963 THROAT IRRITATION 13 0.0003
964 INFUSION RELATED REACTION 19 0.0003
965 CHILLS 33 0.0003
966 MYELOSUPPRESSION 10 0.0003
967 FEBRILE NEUTROPENIA 18 0.0003
968 DYSGEUSIA 20 0.0003
969 ABDOMINAL DISCOMFORT 45 0.0003
970 ALOPECIA 52 0.0003
971 FEELING HOT 16 0.0003
972 BURNING SENSATION 18 0.0003
973 STOMATITIS 15 0.0002
974 ANGIOEDEMA 10 0.0002
975 ACCIDENTAL EXPOSURE TO PRODUCT 23 0.0002
976 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
977 VAGINAL HAEMORRHAGE 9 0.0002
978 EMOTIONAL DISTRESS 25 0.0002
979 BLOOD GLUCOSE INCREASED 38 0.0002
980 NEOPLASM MALIGNANT 13 0.0002
981 PSORIASIS 25 0.0002
982 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
983 ACNE 12 0.0002
984 DEVICE MALFUNCTION 11 0.0002
985 INJECTION SITE HAEMORRHAGE 12 0.0002
986 BREAST CANCER 13 0.0001
987 HOT FLUSH 10 0.0001
988 RHEUMATOID ARTHRITIS 15 0.0001
989 INJECTION SITE PAIN 40 0.0001
990 PRODUCT STORAGE ERROR 11 0.0001
991 INJECTION SITE BRUISING 9 0.0001
992 DEVICE ISSUE 9 0.0001
993 INJECTION SITE ERYTHEMA 12 0.0001
994 MALIGNANT NEOPLASM PROGRESSION 9 0.0001